002332 Zhejiang Xianju Pharmaceutical
- 12.64
- +0.05+0.40%
Zhejiang Xianju Pharmaceutical News
Xianju Pharmaceutical: Notice on acceptance of the application for registration of betahistine mesylate tablets
Xianju Pharmaceutical: Announcement on the consistency evaluation of Neostigmine methosulfate injection
Xianju Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Xianju Pharmaceutical
Xianju Pharmaceutical: Legal Opinion of Shanghai AllBright Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Xianju Pharmaceutical
Xianju Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Xianju Pharmaceutical: 2024 Semi-Annual Financial Report
Xianju Pharmaceutical: Announcement on matters relating to changing and abandoning shareholding companies\' capital increase and share priority pledge payment rights
Xianju Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Xianju Pharmaceutical: Announcement on the intention of the wholly-owned subsidiary Hangzhou Nengcuaixin Medical Technology Co., Ltd. to absorb and merge the wholly-owned subsidiary Hangzhou Ziming Gene Technology Co., Ltd.
Zhejiang Xianju Pharmaceutical: Announcement on the supplementary application for the approval of the registration certificate for the domestic production of methylprednisolone tablets pharmaceutical.
Zhejiang Xianju Pharmaceutical: Announcement on obtaining the domestic pharmaceutical registration certificate for producing pharmaceutical of Levonorgestrel and Ethinylestradiol tablets.
Zhejiang Xianju Pharmaceutical: Announcement on the acceptance of the consistency evaluation notice for acetate dexamethasone tablets.
Zhejiang Xianju Pharmaceutical: Legal Opinion of Shanghai AllBright Law Firm on the 2023 Annual General Meeting of Shareholders of Xianju Pharmaceutical
Zhejiang Xianju Pharmaceutical: 20240522 (2024-027) Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Xianju Pharmaceutical
Xianju Pharmaceutical: Announcement on Continuing Foreign Exchange Hedging Business
Xianju Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Xianju Pharmaceutical: Accounting Services Selection and Employment System
Xianju Pharmaceutical: Notice of Annual Shareholders' Meeting
Xianju Pharmaceutical: Internal Control Self-Evaluation Report
Xianju Pharmaceutical: Regulations on the work of the Audit Committee of the Board of Directors
Analysis
Price Target
No Data
No Data